002898.SZ实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 10:18):

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China...

Stats
今日成交量	1.19M
平均成交量	8.56M
市值	1.75B
EPS	CNY0.00760 ( 2023-09-30 )
下一个收益日期	( CNY0 ) 2024-05-16
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	198.40
ATR14	CNY0.0240 (0.24%)

音量相关性

長: -0.02 (neutral)

短: 0.44 (neutral)

Signal:(59.684) Neutral

Sailong Pharmaceutical 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Sailong Pharmaceutical 相关性 - 货币/商品

-0.21
( neutral )

-0.01
( neutral )

0.00
( neutral )

-0.43
( neutral )

0.22
( neutral )

0.36
( neutral )

Sailong Pharmaceutical 财务报表

Annual	2023
营收:	CNY310.63M
毛利润:	CNY143.47M (46.19 %)
EPS:	CNY0.0542

FY	2023
营收:	CNY310.63M
毛利润:	CNY143.47M (46.19 %)
EPS:	CNY0.0542

FY	2022
营收:	CNY264.19M
毛利润:	CNY141.25M (53.47 %)
EPS:	CNY-0.210

FY	2021
营收:	CNY247.08M
毛利润:	CNY163.61M (66.22 %)
EPS:	CNY-0.133

Financial Reports:

No articles found.

Sailong Pharmaceutical

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium products. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding medicine, analgesics, and other fields. The company was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co., Ltd. in September 2021. Sailong Pharmaceutical Group Co., Ltd. was founded in 2002 and is based in Zhuhai, China.